Biotinylated Recombinant Human MS4A1/CD20 Protein - RP00584BLQ
Catalog #
AB-RP00584BLQ
510,00 €
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.
| Datasheet URL | https://abclonal.com/instructions/pdf/RP00584BLQ |
|---|---|
| Quantity | 100ug |
| Alternative Names | MS4A1; CD20; MS4A-1; B1; Bp35; CD20 receptor; CD20S7; CVID5; LEU-16; Ly-44; MS4A2; S7 |
| Species | Human |
| Source | E. coli |
| Purity | >95%bySDS-PAGE |
| Immunogen | Ile141-Ser188 |
| Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |